Adverse drug reaction to antiparkinson agents in Idiopathic Parkinson Disease: a prospective observational study in a Movement Disorder outpatient clinic (original) (raw)

A Prospective Study of the Drug Prescribing Rate and Pattern and Assessment of Adverse Drug Reactions in Patients with Idiopathic Parkinson Disease in a Tertiary Care Hospital

Am Jour of Phytomed & Clinical Therapeut

American Journal of Phytomedicine and Clinical Therapeutics (AJPCT), 2014

View PDFchevron_right

Drug related problems with Antiparkinsonian agents: consumer Internet reports versus published data

Marion Schaefer

Pharmacoepidemiology and Drug Safety, 2007

View PDFchevron_right

Drug-induced parkinsonism: A review of 17 years' experience in a regional pharmacovigilance center in France

Emmanuelle Bondon-guitton

Movement Disorders, 2011

View PDFchevron_right

Parkinsonism caused by adverse drug reactions: a case series

Solomon Ugoya

Journal of Medical Case Reports, 2011

View PDFchevron_right

Use of antiparkinsonian drugs in Denmark: Results from a nationwide pharmacoepidemiological study

Mette Brandt-Christensen

Movement Disorders, 2006

View PDFchevron_right

Drug prescribing patterns in Parkinson's disease: a pharmacoepidemiological survey in a cohort of ambulatory patients

Marco Cosentino

Pharmacoepidemiology and drug safety, 2002

View PDFchevron_right

Trends in inpatient antiparkinson drug use in the USA, 2001-2012

Donald Mattison

European journal of clinical pharmacology, 2015

View PDFchevron_right

Adverse Reactions to Antipsychotics in Parkinson Disease

carmelo aguirre

Clinical Neuropharmacology, 2015

View PDFchevron_right

Drug-related problems in Parkinson's disease: the role of community pharmacists in primary care

Marion Schaefer

International journal of clinical pharmacy, 2011

View PDFchevron_right

Postural Disorders and Antiparkinsonian Treatments in Parkinson Disease: An Exploratory Case-Control Study

Lucia Ameghino

Clinical Neuropharmacology, 2018

View PDFchevron_right

CASE REPORT: PHARMACOLOGICAL MANAGEMENT IN THE PATIENT WITH PARKINSON'S DISEASE (Atena Editora)

Atena Editora

CASE REPORT: PHARMACOLOGICAL MANAGEMENT IN THE PATIENT WITH PARKINSON'S DISEASE (Atena Editora), 2022

View PDFchevron_right

Prescribing patterns of antiparkinsonian agents in Europe

Cristina Sampaio

Movement Disorders, 2010

View PDFchevron_right

Pharmacologic safety concerns in Parkinson's disease: facts and insights

Jack Chen

The International journal of neuroscience, 2011

View PDFchevron_right

Postural Disorders and Antiparkinsonian Treatments in Parkinson Disease

Lucia Ameghino

Clinical Neuropharmacology, 2018

View PDFchevron_right

Outcomes associated with pharmacologic treatments in Parkinson's disease: a review of recent literature

Amit Kulkarni

Expert Opinion on Pharmacotherapy, 2008

View PDFchevron_right

A case of drug induced dizziness in a patient on anti-Parkinson drugs

Mehnaz Hoda

International Journal of Basic & Clinical Pharmacology

View PDFchevron_right

Disease-Modifying Antirheumatic Drugs and Risk of Parkinson Disease

Markku J Kauppi

Neurology

View PDFchevron_right

Pharmacotherapeutic Challenges in Parkinson’s Disease Inpatients

Unax Lertxundi

Challenges in Parkinson's Disease, 2016

View PDFchevron_right

Patterns and Determinants of Prescribing for Parkinson’s Disease: A Systematic Literature Review

Khalid Orayj

Parkinson's Disease, 2019

View PDFchevron_right

National surveys: a way to manage treatment strategies in Parkinson's disease? Pharmaceutical prescribing patterns and patient experiences of symptom control and their impact on disease

Johan Lökk

Journal of Multidisciplinary Healthcare, 2013

View PDFchevron_right

Antiparkinsonism anticholinergics increase dementia risk in patients with Parkinson's disease

Li-nien Chien

Parkinsonism & Related Disorders, 2019

View PDFchevron_right

gUIDELINE COMPARISON AND ASSESSMENT OF PRESCRIbINg TRENDS IN PARKINSON’S DISEASE

Marise Gauci

2019

View PDFchevron_right

Drug-induced parkinsonism: prevalence, clinical features and follow-up study in three Sicilian communities

Giuseppe Salemi

Journal of Neurology, 1996

View PDFchevron_right

Systematic Evaluation of Rating Scales for Drug-Induced Parkinsonism and Recommendations for Future Research

Carolina Keijsers

Journal of Clinical Psychopharmacology, 2010

View PDFchevron_right

Mortality in a population-based cohort of patients treated with antiparkinsonian drugs

Giuseppe Meco

Acta Neurologica Scandinavica, 2009

View PDFchevron_right

Motor and non-motor symptoms of 1453 patients with Parkinson's disease: Prevalence and risks

Taku Hatano

Parkinsonism & Related Disorders, 2013

View PDFchevron_right

Adherence to antiparkinson medication in a multicenter European study

Pablo Pages

Movement Disorders, 2009

View PDFchevron_right

Associations between Anticholinergic Burden and Adverse Health Outcomes in Parkinson Disease

Yannick Fortin

PLOS ONE, 2016

View PDFchevron_right